To Assess the Bioavailability and Safety of Paclitaxel Injection Concentrate for Suspension in Subjects With Locally Recurrent or Metastatic Breast Cancer
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer|Locally Recurrent Cancer
Interventions: DRUG: PICS (Reconstitution Method 1 or 2)
Sponsor: Sun Pharma Advanced Research Company Limited